Prognostic value of the left ventricular ejection fraction in patients with acute heart failure;Valor pronóstico de la fracción de eyección del ventrículo izquierdo en pacientes con insuficiencia cardíaca aguda

Medicina Clinica

Volumn 131, Issue 5, 2008, Pages 161-166

  Núñez, Julio ^a   Mainar, Luis ^a   Bodí, Vicent ^a   Sanchis, Juan ^a   Núñez, Eduardo ^a   Miñana, Gema ^a   Husser, Oliver ^a   Bosch, María José ^a   Chorro, Francisco J ^a   Llàcer, Àngel ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

Author keywords

Ejection fraction; Heart failure; Prognosis

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; NITRIC ACID DERIVATIVE; SPIRONOLACTONE;

ACUTE HEART FAILURE; ADULT; AGED; ARTICLE; DIAGNOSTIC VALUE; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HOSPITAL READMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; TRANSTHORACIC ECHOCARDIOGRAPHY;

EID: 47649116140     PISSN: 00257753     EISSN: 15788989     Source Type: Journal    
DOI: 10.1157/13124260     Document Type: Article

References (35)

1. Cleland JGF, Swedberg K, Follath F, Komajda M, Cohen-Solal A, Aguilar JC, et al. The EuroHeart Failure survey programme - a survey on the quality of care among patients with heart failure in Europe. Part 1: patient's characteristics and diagnosis. Eur Heart J. 2003;24:442-63.
2. Nieminen MS, Brutsaert D, Dickstein K, Drexler H, Follath F, Harjola V, et al. EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population. Eur Heart J. 2006;27:2725-36.
3. Pocock SJ, Wang D, Pfeffer MA, Yusuf S, McMurray JJ, Swedberg KB, et al. Predictors of mortality and morbidity in patients with chronic heart failure. Eur Heart J. 2006;27:65-75.
4. Burns RJ, Gibbons RJ, Yi Q, Roberts RS, Miller JD, Schaer GL, et al. The relationships of left ventricular ejection fraction, end systolic volume index and infarct size to six months mortality after hospital discharge following myocardial infarction treated by thrombolysis. J Am Coll Cardiol. 2002;39:30-6.
5. Gustafsson F, Torp-Pedersen C, Brendorp B, Seibaek M, Burchardt H, Køber L. Long-term survival in patients hospitalized with congestive heart failure: relation to preserved and reduced left ventricular systolic function. Eur Heart J. 2003;24:863-70.
6. Lenzen MJ, Scholte OP, Remer WJM, Boersma E, Vantrimpont PJMJ, Follath F, et al. Differences between patients with preserved and a depressed left ventricular function: a report from the EuroHeart Failure Survey. Eur Heart J. 2004;25:1214-20.
7. Owan TE, Hodge DO, Herges RM, Jacobsen SJ, Roger VL, Redfield MM. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med. 2006;355:251-9.
8. Adams KF, Fonarow GC, Emerman CL, Le Jemtel TH, Costanzo MR, Abraham WT, et al. Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the acute descompensated. Heart Failure National Registry (ADHERE). Am Heart J. 2005;149:209-16.
9. Tavazzi L, Maggioni AP, Lucci D, Cacciatore G, Ansalone G, Oliva F, et al. Nationwide survey on acute heart failure in cardiology ward services in Italy. Eur Heart J. 2006;27:1207-15.
10. Martínez-Sellés M, García-Robles JA, Prieto L, Frades E, Muñoz R, Díaz-Castro O, et al. Características de los pacientes ingresados por insuficiencia cardíaca según el estado de su función ventricular. Rev Esp Cardiol. 2002;55:579-86.
11. Smith GL, Masoudi FA, Vaccarino V, Radford MJ, Krumholz HM. Outcome in heart failure patients with preserved ejection fraction: mortality, readmision and functional decline. J Am Coll Cardiol. 2003;41:510-8.
12. Macín SM, Perna ER, Címbaro JP, Alvarenga P, Pantich R, Ríos N, et al. Características clínicoevolutivas en la insuficiencia cardíaca descompensada con disfunción sistólica y función sistólica preservada. Rev Esp Cardiol. 2004;57: 45-52.
13. Berry C, Hogg K, Norrie J, Stevenson K, Brett M, McMurray J. Heart failure with preserved left ventricular systolic function: a hospital cohort study. Heart. 2005;91:907-13.
14. Bhatia RS, Tu JV, Lee DS, Austin PC, Fang J, Haouzi A, et al. Outcome of heart failure with preserved ejection fraction in a population-based study. N Engl J Med. 2006;355:260-9.
15. Siirilä-Waris K, Lassus J, Melin J, Peuhkurinen K, Nieminen MS, Harjola V. Characteristics, outcomes, and predictors of 1-year mortality for acute heart failure. Eur Heart J. 2006;27:3011-7.
16. Ojeda S, Anguita M, Muñoz JF, Rodríguez MT, Mesa D, Franco M, et al. Características clínicas y pronóstico de la insuficiencia cardíaca con función sistólica conservada. ¿Es diferente de la insuficiencia cardíaca sistólica? Rev Esp Cardiol. 2003;88:249-4.
17. Varela-Román A, Grigorian L, Barge E, Bastante P, De la Pena MG, González-Juanatey JR. Heart failure in patients with preserved and deteriored left ventricular ejection fraction. Heart. 2005;91:489-94.
18. Tsutsui H, Tsuchihashi M, Takeshita A. Mortality and readmission of hospitalized patients with congestive heart failure and preserved versus depressed systolic function. Am J Cardiol. 2001;88:530-3.
19. Nieminen MS, Böhm M, Cowie MR, Drexler H, Filippatos GS, Jondeau G, et al. Executive summary of the guidelines on the diagnosis and treatment of acute heart failure. Eur Heart J. 2005;26:384-416.
20. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373-83.
21. De Groot V, Beckerman H, Lankhorst GJ, Bouter LM. How to measure comorbidity. A critical review of available methods. J Clin Epidemiol. 2003;56:221-9.
22. Núñez JE, Núñez E, Fácila L, Bertomeu V, Llàcer A, Bodí V, et al. Papel del índice de Charlson en el pronóstico a 30 días y 1 año tras un infarto agudo de miocardio. Rev Esp Cardiol. 2004; 57: 842-9.
23. Fácila Rubio L, Núñez Villota J, Bertomeu González V, Sanchís Fores J, Bodi Peris V, Consuegra Sánchez L, et al. Influencia de la comorbilidad en el manejo intrahospitalario y tratamiento al alta de los pacientes con infarto agudo del miocardio. Med Clin (Barc). 2005;124:447-50.
24. Jacobs DR Jr, Kroenke C, Crow R, Deshpande M, Gu DF, Gatewood L, et al. PREDICT: a simple risk score for clinical severity and long-term prognosis after hospitalization for acute myocardial infarction or unstable angina: the Minnesota Heart Survey. Circulation. 1999;100:599-607.
25. Swedberg K, Cleland J, Dargie H, Drexler H, Follath F, Komajda M, et al. The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005). Eur Heart J. 2005;26:1115-40.
26. Gray RJ. A class of K-sample tests for comparing the cumulative incidence of a competing risk. The Annals of Statistics. 1988;16:1141-54.
27. Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. Journal of the American Statistical Association. 1999;94:496-509.
28. Royston P, Ambler G, Sauerbrei W. The use of fractional polynomials to model continuous risk variables in epidemiology. Int J Epidemiol. 1999; 28: 964-74.
29. Hobbs FD, Roalfe AK, Davis RC, Davies MK, Hare R. Prognosis of all-cause heart failure and borderline left ventricular systolic dysfunction: 5 year mortality follow-up of the Echocardiografic Heart of England Screening Study (ECHOES). Eur Heart J. 2007;28:1128-34.
30. Bursi F, Weston SA, Redfield MM, Jacobsen SJ, Pakhomov S, Nkomo VT, et al. Systolic and diastolic heart failure in the community. JAMA. 2006;296:2209-16.
31. Levy D, Kenchaiah S, Larson MG, Benjamin EJ, Kupka MJ, Ho KKL, et al. Long-term trend in the incidence of and survival with heart failure. N Engl J Med. 2002;347:1397-42.
32. Lee DS, Austin PC, Rouleau JL, Liu PP, Naimark D, Tu JV. Predicting mortality among patients hospitalized for heart failure. Derivation and validation of a clinical model. JAMA. 2003;290:2581-7.
33. Fonarow GC, Abraham WT, Albert NM, Stough WG, Gheorghiade M, Greenberg BH, et al. Carvedilol use at discharge in patients hospitalized for heart failure is associated with improved survival: an analysis from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF). Am Heart J. 2007;153:82.e1-11.
34. Narang R, Cleland JG, Erhardt L, Ball SG, Coats AJ, Cowley AJ, et al. Mode of death in chronic heart failure: a request for more accurate classification. Eur Heart J. 1996;17:1390-403.
35. Myerburg RJ, Kessler KM, Castellanos A. Sudden cardiac death: structure, function and time-dependence of risk. Circulation. 1992;85 1 Suppl:2-10.